Gain Therapeutics Company

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
Industry: Early Drug Development, Preclinical Development
Headquarters: Bethesda, Maryland, United States
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 6
Total Funding: 14396508
Estimated Revenue: Less than $1M
Last Funding Date: 2020-07-21
Last Funding Type: Series B

Visit Website
info@gaintherapeutics.com
Register and Claim Ownership